Cord Blood Registry® (CBR) recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals for $700M. While the announcement was new, there were aspects of the deal that seemed eerily familiar.
[Read more…]
3 Eerie Similarities between the Acquisition of Cord Blood Registry® and ViaCord
Cord Blood Registry® recently made headlines by announcing that it had entered into a definitive agreement to be acquired by AMAG Pharmaceuticals. While the announcement was new, there were aspects of the deal that seemed eerily familiar.
CBR® Acquired by AMAG Pharma for Same Multiple on Revenue as PerkinElmer Paid for ViaCord
In particular, three aspects were strangely reminiscent of the deal in which PerkinElmer acquired the cord blood bank ViaCord in 2007.
[Read more…]
5 Types of Cord Blood Market Participants Impacted by AMAG Pharma’s Acquisition of Cord Blood Registry (CBR®)
On June 29, 2015, AMAG Pharmaceuticals released news that reverberated throughout the cord blood banking industry worldwide, announcing that it had entered into a definitive agreement to acquire Cord Blood Registry (CBR®) for $700 million. The acquisition is expected to close during the third-quarter of 2015, based on regulatory approvals and execution of agreed upon terms and conditions.
Direct Participants in the Cord Blood Deal
Founded in 1992 and headquartered in San Bruno, California, Cord Blood Registry® is the largest cord blood bank in the United States and the world. CBR® currently stores over 500,000 preserved cord blood and cord tissue units, which is substantially more than its nearest competitor, ViaCord, which has approximately 350,000 units stored. [Read more…]
